MRK — Merck & Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapSuper Stock

Annual balance sheet for Merck & Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	—
Status:	Final	Final	Final	Final	fx Preliminary
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	8,096	13,192	7,093	13,689	—
Net Total Accounts Receivable
Net Total Receivables	9,230	10,110	11,072	11,119	—
Total Inventory
Total Other Current Assets
Total Current Assets	30,266	35,722	32,168	38,782	—
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	19,279	22,768	24,488	25,149	—
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	105,694	109,160	106,675	117,106	—
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	23,872	24,239	25,694	28,420	—
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	67,510	63,169	69,094	70,793	—
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	38,184	45,991	37,581	46,313	—
Total Liabilities & Shareholders' Equity	105,694	109,160	106,675	117,106	—
Total Common Shares Outstanding